foxo4-dri human trial (Proxofim) 10mg*10 vials - Nexus peptides FOXO4-DRI improves spermatogenesis in aged

A 2024 pilot study of 45 women with diagnosed endometriosis found that those receiving BPC-157 therapy reported 40% lower pain scores on the Visual Analog Scale compared to baseline after 8 weeks of treatment

1014 Another group of researchers found that individuals with dementia and a caregiver with depression had 73% higher rates of emergency department use over six months than individuals with dementia and a caregiver who did not have depression

Peptide therapy when appropriate to stimulate repair and regeneration

Bone & Periodontal Research BPC-157's angiogenic and fibroblast-activating mechanisms extend to bone healing and periodontal tissue research

Collagen and extracellular matrix support

From accurate dosing to reliable storage, they deliver consistency you can count on